Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Medicinova (MNOV) Return on Sales (2021 - 2025)

Medicinova (MNOV) has disclosed Return on Sales for 8 consecutive years, with 24.83% as the latest value for Q4 2025.

  • Quarterly Return on Sales changed N/A to 24.83% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 31.63% through Dec 2025, changed N/A year-over-year, with the annual reading at 29.32% for FY2025, N/A changed from the prior year.
  • Return on Sales for Q4 2025 was 24.83% at Medicinova, down from 24.65% in the prior quarter.
  • The five-year high for Return on Sales was 0.04% in Q1 2021, with the low at 117.0% in Q1 2022.
  • Average Return on Sales over 5 years is 32.57%, with a median of 8.35% recorded in 2024.
  • The sharpest move saw Return on Sales plummeted -11696bps in 2022, then plummeted -1627bps in 2025.
  • Over 5 years, Return on Sales stood at 0.29% in 2021, then tumbled by -37418bps to 109.63% in 2022, then surged by 93bps to 8.07% in 2023, then fell by -1bps to 8.11% in 2024, then tumbled by -206bps to 24.83% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 24.83%, 24.65%, and 24.38% for Q4 2025, Q3 2025, and Q2 2025 respectively.